MedTrace Logo

Effect of Increased Improve Time on Adhesive System

NCT03254706 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2017-08-29

No results posted yet for this study

Summary

Objective: This double-blind randomized clinical trial evaluates the influence of increased application time of a new etch-and-rinse two-step adhesive Single Link; (Angelus Dental Products Industry) applied in non-carious cervical lesions (NCCLs).

Methods: A total of 221 restorations were randomly placed in 35 patients assigned in four groups to two different etch-and-rinse two-step adhesive Peak® Universal Bond (P) (Ultradent Products Ind) and Single Link (SL) (Angelus Dental Products Industry). The adhesives systems were applied on the NCCLs follows: P1 - applied according to the manufacturer's; P2X - applied for the double time; SL1 and; SL2X. The resin composite Amelogen (Ultradent) was placed incrementally. The restorations were evaluated imediataly (baseline), 6 and 12 months, using the FDI and USPHS criteria. Statistical analyses were performed using appropriate tests (=0.05).

Conditions

  • Clinical Trial

Interventions

OTHER

Peak etch-and-rinse (P1)

Application Mode - Peak Adhesive system applied according to the manufacturer's instructions.

OTHER

Peak applied for double time(P2X)

Application Mode - Peak Adhesive system applied according to the manufacturer's instructions, but for the double time.

OTHER

Single Link etch-and-rinse (SL1)

Application Mode - Single Link Adhesive system applied according to the manufacturer's instructions.

OTHER

Single Link double time (SL2X)

Application Mode - Single Link Adhesive system applied according to the manufacturer's instructions, but for the double time.

Sponsors & Collaborators

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

    collaborator OTHER_GOV

  • Universidade Estadual de Ponta Grossa

    lead OTHER

Principal Investigators

  • Márcio Camargo, Master · Universidade Estadual do Oeste do Paraná

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2017-08-01
Completion
2017-08-01

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03254706 on ClinicalTrials.gov